Sign in
4

Changes in Ownership

Ernexa Therapeutics Inc. Filed Acc 0001019687-15-001090

Options or other derivatives

  • CFO acquired 500,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Wolff Allen · CFO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2015-03-23 Grant or award : show line 1 in the form Stock Options (Right to Buy) +500,000 500,000 D
Loading xslF345X03/wolff_f4.xml…